Vertex Pharmaceuticals Incorporated Reports Second Quarter 2009 Financial Results and Highlights Recent Clinical Progress and Business Development Activity

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reviewed recent business and clinical progress and reported consolidated financial results for the quarter ended June 30, 2009.